Amlodipin Viatris 5 mg

Amlodipin Viatris 5 mg is a medicine authorised by Swissmedic under authorisation number 59261. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 June 2009 and the authorisation is valid without a time limit. ATC code C08CA01 places the medicine in the group Calcium channel blockers.

  • Dispensing category B
  • Authorisation number 59261
  • ATC C08CA01
  • Synthetic medicines
Authorisation data
Authorisation number59261
NameAmlodipin Viatris 5 mg
Full nameAmlodipin Viatris 5 mg, Tabletten
Authorisation holderViatris Pharma GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC08CA01
First authorisation03 June 2009
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Amlodipin Viatris 5 mg, TablettenB03 June 2009
2Amlodipin Viatris 10 mg, TablettenB03 June 2009

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
730Tablette(n)C08CA0102.06.1.B
8100Tablette(n)C08CA0102.06.1.B
930Tablette(n)C08CA0102.06.1.B
10100Tablette(n)C08CA0102.06.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Amlodipin Viatris 5 mg authorised in Switzerland?

Yes. Amlodipin Viatris 5 mg is authorised by Swissmedic under authorisation number 59261, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Amlodipin Viatris 5 mg have?

Amlodipin Viatris 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Amlodipin Viatris 5 mg?

The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com